Selected research
Industry Research
Glutamate Carboxypeptidase 2 Industry Research Report 2026
Market perspective
The global Glutamate Carboxypeptidase 2 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glutamate Carboxypeptidase 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glutamate Carboxypeptidase 2 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glutamate Carboxypeptidase 2 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glutamate Carboxypeptidase 2 include Eisai Co Ltd, Inovio Pharmaceuticals Inc, Crescendo Biologics Ltd and Cerecor Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glutamate Carboxypeptidase 2 market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glutamate Carboxypeptidase 2 Market by Company
Eisai Co Ltd
Inovio Pharmaceuticals Inc
Crescendo Biologics Ltd
Cerecor Inc
Glutamate Carboxypeptidase 2 Segment by Type
INO-5150
E-2072
Others
Glutamate Carboxypeptidase 2 Segment by Application
Glioblastoma Multiforme
Congnitive Impairment
Prostate Cancer
Neuropathic Pain
Others
Glutamate Carboxypeptidase 2 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glutamate Carboxypeptidase 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glutamate Carboxypeptidase 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glutamate Carboxypeptidase 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glutamate Carboxypeptidase 2 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glutamate Carboxypeptidase 2 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glutamate Carboxypeptidase 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- INO-5150
- E-2072
- Others
Applications
- Glioblastoma Multiforme
- Congnitive Impairment
- Prostate Cancer
- Neuropathic Pain
- Others
Companies covered
- Eisai Co Ltd
- Inovio Pharmaceuticals Inc
- Crescendo Biologics Ltd
- Cerecor Inc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glutamate Carboxypeptidase 2 Market Size (2021-2032)
- 2.2.2 Global Glutamate Carboxypeptidase 2 Sales (2021-2032)
- 2.2.3 Global Glutamate Carboxypeptidase 2 Market Average Price (2021-2032)
- 2.3 Glutamate Carboxypeptidase 2 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 INO-5150
- 2.3.3 E-2072
- 2.3.4 Others
- 2.4 Glutamate Carboxypeptidase 2 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Glioblastoma Multiforme
- 2.4.3 Congnitive Impairment
- 2.4.4 Prostate Cancer
- 2.4.5 Neuropathic Pain
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glutamate Carboxypeptidase 2 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glutamate Carboxypeptidase 2 Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Glutamate Carboxypeptidase 2 Revenue of Manufacturers (2021-2026)
- 3.4 Global Glutamate Carboxypeptidase 2 Average Price by Manufacturers (2021-2026)
- 3.5 Global Glutamate Carboxypeptidase 2 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glutamate Carboxypeptidase 2, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glutamate Carboxypeptidase 2, Product Type & Application
- 3.8 Global Manufacturers of Glutamate Carboxypeptidase 2, Established Date
- 3.9 Global Glutamate Carboxypeptidase 2 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eisai Co Ltd
- 4.1.1 Eisai Co Ltd Company Information
- 4.1.2 Eisai Co Ltd Business Overview
- 4.1.3 Eisai Co Ltd Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eisai Co Ltd Glutamate Carboxypeptidase 2 Product Portfolio
- 4.1.5 Eisai Co Ltd Recent Developments
- 4.2 Inovio Pharmaceuticals Inc
- 4.2.1 Inovio Pharmaceuticals Inc Company Information
- 4.2.2 Inovio Pharmaceuticals Inc Business Overview
- 4.2.3 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Inovio Pharmaceuticals Inc Glutamate Carboxypeptidase 2 Product Portfolio
- 4.2.5 Inovio Pharmaceuticals Inc Recent Developments
- 4.3 Crescendo Biologics Ltd
- 4.3.1 Crescendo Biologics Ltd Company Information
- 4.3.2 Crescendo Biologics Ltd Business Overview
- 4.3.3 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Crescendo Biologics Ltd Glutamate Carboxypeptidase 2 Product Portfolio
- 4.3.5 Crescendo Biologics Ltd Recent Developments
- 4.4 Cerecor Inc
- 4.4.1 Cerecor Inc Company Information
- 4.4.2 Cerecor Inc Business Overview
- 4.4.3 Cerecor Inc Glutamate Carboxypeptidase 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Cerecor Inc Glutamate Carboxypeptidase 2 Product Portfolio
- 4.4.5 Cerecor Inc Recent Developments
5 Global Glutamate Carboxypeptidase 2 Market Scenario by Region
- 5.1 Global Glutamate Carboxypeptidase 2 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glutamate Carboxypeptidase 2 Sales by Region: 2021-2032
- 5.2.1 Global Glutamate Carboxypeptidase 2 Sales by Region: 2021-2026
- 5.2.2 Global Glutamate Carboxypeptidase 2 Sales by Region: 2027-2032
- 5.3 Global Glutamate Carboxypeptidase 2 Revenue by Region: 2021-2032
- 5.3.1 Global Glutamate Carboxypeptidase 2 Revenue by Region: 2021-2026
- 5.3.2 Global Glutamate Carboxypeptidase 2 Revenue by Region: 2027-2032
- 5.4 North America Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
- 5.4.1 North America Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glutamate Carboxypeptidase 2 Sales by Country (2021-2032)
- 5.4.3 North America Glutamate Carboxypeptidase 2 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
- 5.5.1 Europe Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glutamate Carboxypeptidase 2 Sales by Country (2021-2032)
- 5.5.3 Europe Glutamate Carboxypeptidase 2 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glutamate Carboxypeptidase 2 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glutamate Carboxypeptidase 2 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
- 5.7.1 South America Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glutamate Carboxypeptidase 2 Sales by Country (2021-2032)
- 5.7.3 South America Glutamate Carboxypeptidase 2 Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Glutamate Carboxypeptidase 2 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glutamate Carboxypeptidase 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glutamate Carboxypeptidase 2 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glutamate Carboxypeptidase 2 Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Glutamate Carboxypeptidase 2 Sales by Type (2021-2032)
- 6.1.1 Global Glutamate Carboxypeptidase 2 Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Glutamate Carboxypeptidase 2 Sales Market Share by Type (2021-2032)
- 6.2 Global Glutamate Carboxypeptidase 2 Revenue by Type (2021-2032)
- 6.2.1 Global Glutamate Carboxypeptidase 2 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glutamate Carboxypeptidase 2 Revenue Market Share by Type (2021-2032)
- 6.3 Global Glutamate Carboxypeptidase 2 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glutamate Carboxypeptidase 2 Sales by Application (2021-2032)
- 7.1.1 Global Glutamate Carboxypeptidase 2 Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Glutamate Carboxypeptidase 2 Sales Market Share by Application (2021-2032)
- 7.2 Global Glutamate Carboxypeptidase 2 Revenue by Application (2021-2032)
- 7.2.1 Global Glutamate Carboxypeptidase 2 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glutamate Carboxypeptidase 2 Revenue Market Share by Application (2021-2032)
- 7.3 Global Glutamate Carboxypeptidase 2 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glutamate Carboxypeptidase 2 Value Chain Analysis
- 8.1.1 Glutamate Carboxypeptidase 2 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glutamate Carboxypeptidase 2 Production Mode & Process
- 8.2 Glutamate Carboxypeptidase 2 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glutamate Carboxypeptidase 2 Distributors
- 8.2.3 Glutamate Carboxypeptidase 2 Customers
9 Global Glutamate Carboxypeptidase 2 Analyzing Market Dynamics
- 9.1 Glutamate Carboxypeptidase 2 Industry Trends
- 9.2 Glutamate Carboxypeptidase 2 Industry Drivers
- 9.3 Glutamate Carboxypeptidase 2 Industry Opportunities and Challenges
- 9.4 Glutamate Carboxypeptidase 2 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst